MIDDLETON, Wis.--(BUSINESS WIRE)--Imbed Biosciences (“Imbed”), a pioneer in breakthrough wound care synthetic matrix technology, today announced the U.S. Food and Drug Administration (FDA) has ...

The addition to its KVM matrix portfolio brings enterprise-grade KVM capabilities to more streamlined applications with a ‘plug and play’ architecture When you purchase through links on our site, we ...

The MarketWatch News Department was not involved in the creation of this content. Leaders in the CPM market include Board, Infor EPM, Oracle EPM, Prophix, Vena Solutions, and Wolters Kluwer CCH ...